-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Assumes Guardant Health at Outperform, Announces Price Target of $150

Benzinga·06/02/2026 12:33:20
Listen to the news
Wolfe Research analyst Mike Polark assumes Guardant Health (NASDAQ:GH) with a Outperform rating and announces Price Target of $150.